UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MRK — Merck & Co., Inc.
CIK 861177
NEW YORK, NY
Position in MRK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,455,698,571
+$410,138,576 QoQ
Shares Held
20,414,819
+5.1% QoQ
Ownership
0.827%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52.40577935077455.ToString("F0")%
Shared 0.ToString("F0")%
None 47.59422064922545.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. MRK ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,455,698,571 | 20,414,819 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,045,559,995 | 19,433,403 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,657,606,161 | 19,749,865 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,989,554,316 | 25,133,329 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,861,395,927 | 20,737,477 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,143,570,960 | 21,547,758 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,016,373,736 | 17,756,021 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,159,859,981 | 17,446,365 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,655,625,466 | 12,547,370 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,381,279,796 | 12,669,967 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,302,529,983 | 12,652,064 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,373,799,525 | 11,905,707 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,266,648,162 | 11,905,707 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,356,664,529 | 12,227,711 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,047,461,105 | 12,162,809 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,084,683,852 | 11,897,377 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $974,851,879 | 11,881,193 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $930,359,011 | 12,139,340 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $953,796,046 | 12,698,656 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $904,376,358 | 11,628,859 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $901,957,896 | 12,261,660 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $948,029,021 | 12,145,903 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $988,723,927 | 12,491,648 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $899,009,230 | 12,183,645 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,032,827,221 | 14,068,149 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||